Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
As we mentioned on our list of the top 30 venture capital firms of 2013, VC is part of what makes new biotechs and biopharmas blossom. Although our list is over three pages long and there seem to be an abundance of VC firms funding biopharma startups, have you ever had any problems getting capital for one of your ventures?